Webinar Series

HOW TO KEEP YOUR BUSINESS RUNNING: CORPORATE HEALTH THROUGH COVID-19

BIOTECanada is pleased to draw on its members’ expertise to bring you practical business advice during this global crisis. Recordings of past webinars can be found here. Please refer to our events calendar for upcoming sessions.

Session 1: Biopharma Exit Outlook in the Age of COVID-19
Silicon Valley Bank – Jon Norris & Anne Woods

Session 2: Canadian immigration and the effects of COVID-19
Farris LLP – Ryan Neely

Session 3: Economic Outlooks & Navigating IRAP’s Innovation Assistance Program
Deloitte – Anita Shinde, Joyce Drohan, Stephen Lopes, and Jason Ding

Session 4: Managing the ever-changing workplace during COVID-19: What employers need to know
Norton Rose Fulbright – Heather Cameron & Chantal Arsenault

Session 5: Government Economic Assistance for Biotech Companies
Gowling WLG – Colin Green, Neena Gupta, Ted Thiessen

Session 6: Enhancements to biotech funding programs during COVID-19
BioTalent Canada – Rob Henderson

Session 7: Data Hubs for Health Solutions: Protecting the Value of your Data
Norton Rose Fulbright – Maya Medeiros & Alexis Kerr

Session 8: Business Stability, Contractual Relationships and Risk Management
Gowling WLG – Cynthia Elderkin, Jahmiah Ferdinand-Hodkin, Lorraine Mastersmith

Session 9: Managing Drug Supply in Canada: Lessons learned and future risk
Pangaea Group – Kyra Trainor & Marc Lafoley

Sessions 10: Maximizing Your Investment Partnering Meetings at BIO 2020 (PART 1)
C├ędric Bisson (Teralys Capital), Maha Katabi (Sofinnova Investments), Gordon McCauley (adMare BioInnovations)

Session 11: Maximizing Your Investment Partnering Meetings at BIO 2020 (PART 2)
Jamie Stiff (Genesys Capital), Anne Woods (SVB), Gordon McCauley (adMare BioInnovations)